Literature DB >> 16754293

Neuropsychological deficits associated with a tumour in the posterior corpus callosum: a report of two cases.

Aiko Osawa1, Shinichiro Maeshima, Kenji Kubo, Toru Itakura.   

Abstract

This study reports two patients with tumours arising from the splenium of the corpus callosum that caused a memory disturbance consistent with retrosplenial amnesia as well as a variety of cognitive deficits including agraphia, acalculia, constructional apraxia and ideomotor and ideational apraxia involving both hands, but not aphasia. Patients showed disorientation to time and place, impaired recent memory and memorizing capacity; immediate and remote memory were preserved. Despite impaired performance intelligence quotients (IQ), verbal IQ was relatively spared. Patients also showed disconnection symptoms including bilateral crossed visuomotor ataxia and alexia to stimuli presented in the right visual field. In both cases, the tumour of the splenium had provoked surrounding oedema extending to the left parietal and occipital lobes.

Entities:  

Mesh:

Year:  2006        PMID: 16754293     DOI: 10.1080/02699050600676958

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  10 in total

1.  Relationship between intelligence and the size and composition of the corpus callosum.

Authors:  Amanda D Hutchinson; J L Mathias; B L Jacobson; L Ruzic; A N Bond; Marie T Banich
Journal:  Exp Brain Res       Date:  2008-10-24       Impact factor: 1.972

2.  Improved outcomes associated with maximal extent of resection for butterfly glioblastoma: insights from institutional and national data.

Authors:  Alessandro Boaro; Vasileios K Kavouridis; Francesca Siddi; Elisabetta Mezzalira; Maya Harary; J Bryan Iorgulescu; David A Reardon; Timothy R Smith
Journal:  Acta Neurochir (Wien)       Date:  2021-04-19       Impact factor: 2.216

3.  Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes.

Authors:  Kristine Dziurzynski; David Blas-Boria; Dima Suki; Daniel P Cahill; Sujit S Prabhu; Vinay Puduvalli; Nicholas Levine
Journal:  J Neurooncol       Date:  2012-07-18       Impact factor: 4.130

4.  Rare case of glioblastoma multiforme located in posterior corpus callosum presenting with depressive symptoms and visual memory deficits.

Authors:  Hale Yapıcı-Eser; Aslıhan Onay; Özgür Öztop-Çakmak; Emrah Egemen; Ebru Nur Vanlı-Yavuz; İhsan Solaroğlu
Journal:  BMJ Case Rep       Date:  2016-12-15

5.  Primary CNS lymphoma of the corpus callosum: presentation and neurocognitive outcomes.

Authors:  Christelle Nilles; Daniel Delgadillo; Marie Sarazin; Lucia Nichelli; Karima Mokhtari; Bertrand Mathon; Sylvain Choquet; Loïc Feuvret; Agusti Alentorn; Monica Ribeiro; Khê Hoang-Xuan; Caroline Houillier
Journal:  J Neurooncol       Date:  2022-04-21       Impact factor: 4.130

6.  The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors?

Authors:  Kaisorn L Chaichana; Ignacio Jusue-Torres; Ana Maria Lemos; Aaron Gokaslan; Eibar Ernesto Cabrera-Aldana; Ahmed Ashary; Alessandro Olivi; Alfredo Quinones-Hinojosa
Journal:  J Neurooncol       Date:  2014-09-06       Impact factor: 4.130

Review 7.  Cholinergic modulation of spatial learning, memory and navigation.

Authors:  Nicola Solari; Balázs Hangya
Journal:  Eur J Neurosci       Date:  2018-08-19       Impact factor: 3.386

8.  Reversible verbal and visual memory deficits after left retrosplenial infarction.

Authors:  Jong Hun Kim; Kwang-Yeol Park; Sang Won Seo; Duk L Na; Chin-Sang Chung; Kwang Ho Lee; Gyeong-Moon Kim
Journal:  J Clin Neurol       Date:  2007-03-20       Impact factor: 3.077

Review 9.  Neuropsychological features of lesion-related epilepsy in adults: an overview.

Authors:  Chris E Morrison; Luba Nakhutina
Journal:  Neuropsychol Rev       Date:  2007-10-19       Impact factor: 6.940

10.  Cavernous angioma of the corpus callosum presenting with acute psychosis.

Authors:  Giacomo Pavesi; Francesco Causin; Alberto Feletti
Journal:  Behav Neurol       Date:  2014-03-05       Impact factor: 3.342

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.